Gattamaneni HR - Search Results

1

Does growth hormone cause relapse of brain tumours?

Clayton PE, Shalet SM, Gattamaneni HR, Price DA. Clayton PE, et al. Among authors: gattamaneni hr. Lancet. 1987 Mar 28;1(8535):711-3. doi: 10.1016/s0140-6736(87)90355-2. Lancet. 1987. PMID: 2882131

2

Relapse of intracranial germinoma 23 years postirradiation in a patient given growth hormone replacement.

Kiltie AE, Collins CD, Gattamaneni HR, Shalet SM. Kiltie AE, et al. Among authors: gattamaneni hr. Med Pediatr Oncol. 1997 Jul;29(1):41-4. doi: 10.1002/(sici)1096-911x(199707)29:1<41::aid-mpo8>3.0.co;2-s. Med Pediatr Oncol. 1997. PMID: 9142205

3

Long-term safety of growth hormone replacement after CNS irradiation.

Mackenzie S, Craven T, Gattamaneni HR, Swindell R, Shalet SM, Brabant G. Mackenzie S, et al. Among authors: gattamaneni hr. J Clin Endocrinol Metab. 2011 Sep;96(9):2756-61. doi: 10.1210/jc.2011-0112. Epub 2011 Jun 29. J Clin Endocrinol Metab. 2011. PMID: 21715535

4

Growth hormone and tumour recurrence.

Ogilvy-Stuart AL, Ryder WD, Gattamaneni HR, Clayton PE, Shalet SM. Ogilvy-Stuart AL, et al. Among authors: gattamaneni hr. BMJ. 1992 Jun 20;304(6842):1601-5. doi: 10.1136/bmj.304.6842.1601. BMJ. 1992. PMID: 1628087 Free PMC article.

5

The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval.

Darzy KH, Aimaretti G, Wieringa G, Gattamaneni HR, Ghigo E, Shalet SM. Darzy KH, et al. Among authors: gattamaneni hr. J Clin Endocrinol Metab. 2003 Jan;88(1):95-102. doi: 10.1210/jc.2002-021094. J Clin Endocrinol Metab. 2003. PMID: 12519836

6

Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement.

Gleeson HK, Stoeter R, Ogilvy-Stuart AL, Gattamaneni HR, Brennan BM, Shalet SM. Gleeson HK, et al. Among authors: gattamaneni hr. J Clin Endocrinol Metab. 2003 Aug;88(8):3682-9. doi: 10.1210/jc.2003-030366. J Clin Endocrinol Metab. 2003. PMID: 12915655

7

Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy.

Gleeson HK, Gattamaneni HR, Smethurst L, Brennan BM, Shalet SM. Gleeson HK, et al. Among authors: gattamaneni hr. J Clin Endocrinol Metab. 2004 Feb;89(2):662-6. doi: 10.1210/jc.2003-031224. J Clin Endocrinol Metab. 2004. PMID: 14764778

8

Pubertal growth in response to testosterone replacement therapy for radiation-induced Leydig cell failure.

Didi M, Morris-Jones PH, Gattamaneni HR, Shalet SM. Didi M, et al. Among authors: gattamaneni hr. Med Pediatr Oncol. 1994;22(4):250-4. doi: 10.1002/mpo.2950220407. Med Pediatr Oncol. 1994. PMID: 8107655

9

Thyroid function after treatment of brain tumors in children.

Ogilvy-Stuart AL, Shalet SM, Gattamaneni HR. Ogilvy-Stuart AL, et al. Among authors: gattamaneni hr. J Pediatr. 1991 Nov;119(5):733-7. doi: 10.1016/s0022-3476(05)80288-4. J Pediatr. 1991. PMID: 1941379

10

Effect of abdominal irradiation on growth in boys treated for a Wilms' tumor.

Wallace WH, Shalet SM, Morris-Jones PH, Swindell R, Gattamaneni HR. Wallace WH, et al. Among authors: gattamaneni hr. Med Pediatr Oncol. 1990;18(6):441-6. doi: 10.1002/mpo.2950180602. Med Pediatr Oncol. 1990. PMID: 2172754

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters